Provided is an otitis media treatment instrument and, more particularly, to an otitis media treatment instrument having a ventilation tube installed thereon, the otitis media treatment instrument including: a cutting sheath which is configured in a tube shape, and which has an inner diameter larger than the outer diameter of the ventilation tube; and a suction pipe formed to be able to move relative to the cutting sheath inside the cutting sheath along the longitudinal direction of the cutting sheath, the suction pipe having, on the front end portion thereof, an insertion portion having an outer diameter smaller than the inner diameter of the ventilation tube and having a fixing portion which extends toward the front end of the insertion portion, and which has an outer diameter larger than the inner diameter of the ventilation tube.

Described here are devices, systems, and methods for treating conditions or diseases of the nose, ear, or throat with an expandable device having a drug coating. The expandable devices may be delivered to a body cavity in a low-profile configuration and expanded to contact surrounding tissue. The expandable devices may deliver or release the drug coating to the tissue. Multiple expansions of a single device may be employed during treatment. Various coating excipients and manufacturing parameters for the expandable devices may also be adjusted to enhance or slow transfer of the drug coating and/or release of the drug to the target tissue site. The drug transferred to the tissue may act as an in situ depot that enables maintenance of a therapeutic level of locally delivered drug for a desired time period after removal of the expandable devices.

Described here are devices, systems, and methods for treating conditions or diseases of the nose, ear, or throat with an expandable device having a drug coating. The expandable devices may be delivered to a body cavity in a low-profile configuration and expanded to contact surrounding tissue. The expandable devices may deliver or release the drug coating to the tissue. Multiple expansions of a single device may be employed during treatment. Various coating excipients and manufacturing parameters for the expandable devices may also be adjusted to enhance or slow transfer of the drug coating and/or release of the drug to the target tissue site. The drug transferred to the tissue may act as an in situ depot that enables maintenance of a therapeutic level of locally delivered drug for a desired time period after removal of the expandable devices.

An aspirator for manually collecting liquid sample, particularly for medical purposes, comprising a handle connected to a vacuum source and having a sample collection vial fitting into a cavity in the handle with a thumb control vent slot in the top of the handle to selectively control suction required to collect the liquid sample. A tubing functions as the probe for the sample to be collected. The tubing leads into the sample collection vial.

A system and method for use in iontophoretic anesthesia of a tympanic membrane are disclosed. The system generally includes an earplug and an electrode device. The earplug includes at least one sealing member for sealing the earplug in an ear canal. The sealing member includes microholes which vent fluid above a certain pressure threshold. A headset may connect the earplug to a second earplug. The method involves using the system on a human or animal subject.

The invention provides liquid formulation compositions and medicament delivery devices, and methods for preparing and using the same. For example, the liquid formulation composition is an emulsion including a solvent and liquid particles, which includes surfactants and are dispersed in the solvent. The volume average particle size of the liquid particles is less than about 100 m; the surface tension of the liquid formulation composition is less than about 60 mN/m; and the absolute value of zeta potential is greater than about 15 mV. The containment vessel may be a sprayer or a dropping device. The invention also provides methods for preparation of the liquid formulation compositions and medicament delivery devices as well as methods for using the same in treatment of various diseases and condition, for example, otitis media, otitis externa, rhinitis, sinusitis, lower respiratory tract inflammation, xerostomia (dry mouth), xerophthalmia (dry eyes) and xeromycteria (dry nose).

A prosthesis including a device configured to deliver a therapeutic substance from outside a cochlea to inside the cochlea and configured to evoke a mechanically based hearing percept. In an exemplary embodiment, the device is configured to drive fluid into and out of the cochlea, thereby evoking a hearing percept.

Described here are systems and methods for delivering an active agent to target tissues of the ear, nose, or throat using an expandable member having drug crystals layered thereon, and methods for manufacturing such systems. The expandable member can be delivered to the target tissues in a low-profile configuration and expanded to contact and/or dilate surrounding tissue. Expansion of the expandable member transfers the drug crystals to the target tissues, which then act as an in situ depot that enables maintenance of a therapeutic level of an active agent for a desired time period after removal of the expandable member. Multiple expansions of a single expandable member can be employed during treatment. For example, the systems and methods can be useful when it is desired to treat multiple paranasal sinuses with a single expandable member.

An instrument includes a handle assembly, a shaft, a dilation catheter, and a position sensor. The shaft extends distally from the handle assembly. The shaft includes a distal end that is configured to be introduced into an anatomical passageway within a head of a human. The dilation catheter includes an expandable dilator and is configured to advance distally relative to the shaft. The position sensor is configured to generate signals indicating a position of the position sensor within the head. The position sensor is configured to advance distally between at least first and second positions. The position sensor is disposed adjacent the distal end of the shaft in the first position, and is configured to be carried further distally by the dilation catheter to the second position. In the second position, the position sensor is separated a distance from the distal end of the shaft.

An apparatus includes a handle assembly, a guide member extending distally from the handle assembly, and a dilation catheter slidably disposed relative to the guide member. The dilation catheter includes an expandable element configured to dilate a paranasal sinus ostium of a patient. A navigation sensor is movably disposed at the distal end of the guide member and is operable to generate a signal corresponding to a location thereof within the patient. The navigation sensor is configured to translate distally with the dilation catheter relative to the guide member when a distal end of the dilation catheter translates distally beyond the distal end of the guide member. The navigation sensor is further configured to assume a position at the distal end of the guide member when the distal end of the dilation catheter retracts proximally of the distal end of the guide member.